These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22906586)

  • 1. Ureteroneocystostomy after failed dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux treatment.
    Moreira-Pinto J; Osório A; Pereira J; Sousa C; de Castro JL; Réis A
    J Pediatr Urol; 2013 Oct; 9(5):665-9. PubMed ID: 22906586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open ureteroneocystostomy after failed endoscopic injection with three different bulking agents for the treatment of vesicoureteral reflux.
    Sencan A; Yıldırım H; Ozkan KU; Uçan B; Hoşgör M
    J Pediatr Surg; 2014 Nov; 49(11):1652-5. PubMed ID: 25475812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
    Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
    J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
    Molitierno JA; Scherz HC; Kirsch AJ
    J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
    Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
    J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
    Stenberg A; Larsson E; Läckgren G
    J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
    Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
    J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (Deflux).
    Van Batavia JP; Nees SN; Fast AM; Combs AJ; Glassberg KI
    J Pediatr Urol; 2014 Jun; 10(3):482-7. PubMed ID: 24290224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux.
    Routh JC; Ashley RA; Sebo TJ; Vandersteen DR; Slezak J; Reinberg Y
    J Urol; 2007 Oct; 178(4 Pt 2):1707-10. PubMed ID: 17707018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates.
    Bar-Yosef Y; Castellan M; Joshi D; Labbie A; Gosalbez R
    J Urol; 2011 Jun; 185(6 Suppl):2531-4. PubMed ID: 21555029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.